Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts.

[1]  W. Hozack,et al.  Transforming Growth Factor-β-mediated Chondrogenesis of Human Mesenchymal Progenitor Cells Involves N-cadherin and Mitogen-activated Protein Kinase and Wnt Signaling Cross-talk* , 2003, Journal of Biological Chemistry.

[2]  F. Lecanda,et al.  Gap Junctional Communication Modulates Gene Transcription by Altering the Recruitment of Sp1 and Sp3 to Connexin-response Elements in Osteoblast Promoters* , 2003, Journal of Biological Chemistry.

[3]  S. Nagata,et al.  Regulation of Myeloid Zinc Finger Protein 2A Transactivation Activity through Phosphorylation by Mitogen-activated Protein Kinases* , 2003, The Journal of Biological Chemistry.

[4]  Baoguang Han,et al.  Regulation of Gene Expression by Internal Ribosome Entry Sites or Cryptic Promoters: the eIF4G Story , 2002, Molecular and Cellular Biology.

[5]  T. Zander,et al.  Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARγ , 2002 .

[6]  L. Boxer,et al.  A Myc-associated Zinc Finger Protein-related Factor Binding Site Is Required for the Deregulation of c-mycExpression by the Immunoglobulin Heavy Chain Gene Enhancers in Burkitt's Lymphoma* , 2002, The Journal of Biological Chemistry.

[7]  P. Marie.  Role of N‐cadherin in bone formation , 2002, Journal of cellular physiology.

[8]  L. Chung,et al.  Regulation of Human Osteocalcin Promoter in Hormone-independent Human Prostate Cancer Cells* , 2002, The Journal of Biological Chemistry.

[9]  J. Deng,et al.  The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.

[10]  T. Steinberg,et al.  Intercellular Junctions and Cell-Cell Communication in Bone , 2002 .

[11]  L. Ala‐Kokko,et al.  SP3 Represses the SP1-mediated Transactivation of the HumanCOL2A1 Gene in Primary and De-differentiated Chondrocytes* , 2001, The Journal of Biological Chemistry.

[12]  J. Lemonnier,et al.  Protein kinase C-dependent upregulation of N-cadherin expression by phorbol ester in human calvaria osteoblasts. , 2001, Experimental cell research.

[13]  C. Dani,et al.  Impaired ossification in mice lacking the transcription factor Sp3 , 2001, Mechanisms of Development.

[14]  R. Tuan,et al.  Wnt regulation of limb mesenchymal chondrogenesis is accompanied by altered N‐cadherin‐related functions , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  J. Lemonnier,et al.  Role of N‐Cadherin and Protein Kinase C in Osteoblast Gene Activation Induced by the S252W Fibroblast Growth Factor Receptor 2 Mutation in Apert Craniosynostosis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  P. Marie,et al.  Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. , 2001, The Journal of clinical investigation.

[17]  J. Lemonnier,et al.  Fibroblast growth factor‐2 (FGF‐2) increases N‐cadherin expression through protein kinase C and Src‐kinase pathways in human calvaria osteoblasts , 2001, Journal of cellular biochemistry.

[18]  Su‐Li Cheng,et al.  A Dominant Negative Cadherin Inhibits Osteoblast Differentiation , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  F. Lecanda,et al.  Relative abundance of different cadherins defines differentiation of mesenchymal precursors into osteogenic, myogenic, or adipogenic pathways , 2000, Journal of cellular biochemistry.

[20]  J. Morris,et al.  Human myeloid zinc finger gene MZF produces multiple transcripts and encodes a SCAN box protein. , 2000, Gene.

[21]  F. Lecanda,et al.  Differential regulation of cadherins by dexamethasone in human osteoblastic cells , 2000, Journal of cellular biochemistry.

[22]  J. Lemonnier,et al.  N‐ and E‐cadherin mediate early human calvaria osteoblast differentiation promoted by bone morphogenetic protein‐2 , 2000 .

[23]  Stuart A. Aaronson,et al.  Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis , 2000, The Journal of cell biology.

[24]  L. Suva,et al.  A Role for N‐Cadherin in the Development of the Differentiated Osteoblastic Phenotype , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  K. Takaoka,et al.  TNF‐α and IL‐1β Suppress N‐Cadherin Expression in MC3T3‐E1 Cells , 1999 .

[26]  G. Suske.  The Sp-family of transcription factors. , 1999, Gene.

[27]  G Brabant,et al.  The cadherin-catenin system: implications for growth and differentiation of endocrine tissues. , 1999, Endocrine reviews.

[28]  Shu-Yun Le,et al.  Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription , 1998, Oncogene.

[29]  R. Hromas,et al.  The myeloid zinc finger gene (MZF-1) delays retinoic acid-induced apoptosis and differentiation in myeloid leukemia cells , 1998, Leukemia.

[30]  F. Lecanda,et al.  Human Osteoblasts Express a Repertoire of Cadherins, Which Are Critical for BMP‐2–Induced Osteogenic Differentiation , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  M. Mareel,et al.  E‐cadherin/catenin/cytoskeleton complex: A regulator of cancer invasion , 1997, Journal of cellular physiology.

[32]  O. Flores,et al.  Binding of SP1 to the immediate-early protein-responsive element of the human cytomegalovirus DNA polymerase promoter , 1997, Journal of virology.

[33]  N. Paradies,et al.  Isolation and characterization of the promoter region of the chicken N-cadherin gene. , 1997, Gene.

[34]  Barbara Majello,et al.  Sp3 Is a Bifunctional Transcription Regulator with Modular Independent Activation and Repression Domains* , 1997, The Journal of Biological Chemistry.

[35]  L. Gerstenfeld,et al.  Structural analysis and characterization of tissue and hormonal responsive expression of the avian bone sialoprotein (BSP) gene , 1997, Journal of cellular biochemistry.

[36]  A. Patel,et al.  Differential regulation of the c-MYC P1 and P2 promoters in the absence of functional tumor suppressors: implications for mechanisms of deregulated MYC transcription. , 1997, Current topics in microbiology and immunology.

[37]  R Kemler,et al.  A role for cadherins in tissue formation. , 1996, Development.

[38]  B. Gumbiner,et al.  Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis , 1996, Cell.

[39]  John P. Bilezikian,et al.  Principles of Bone Biology , 1996 .

[40]  M. Klemsz,et al.  Hematopoietic transcriptional regulation by the myeloid zinc finger gene, MZF-1. , 1996, Current topics in microbiology and immunology.

[41]  G. Stein,et al.  Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. , 1995, Biochemistry.

[42]  M. Klemsz,et al.  The myeloid zinc finger gene, MZF-1, regulates the CD34 promoter in vitro. , 1995, Blood.

[43]  B Calabretta,et al.  Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity , 1995, Molecular and cellular biology.

[44]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[45]  M. Takeichi.  Morphogenetic roles of classic cadherins. , 1995, Current opinion in cell biology.

[46]  R. Cancedda,et al.  N-CAM and N-cadherin expression during in vitro chondrogenesis. , 1994, Experimental cell research.

[47]  J. Millán,et al.  Expression of N-cadherin and alkaline phosphatase in chick limb bud mesenchymal cells: regulation by 1,25-dihydroxyvitamin D3 or TGF-beta 1. , 1994, Experimental cell research.

[48]  M. Beato,et al.  Sp1‐mediated transcriptional activation is repressed by Sp3. , 1994, The EMBO journal.

[49]  M. Fox,et al.  Structure of the human N-cadherin gene: YAC analysis and fine chromosomal mapping to 18q11.2. , 1994, Genomics.

[50]  R. Hromas,et al.  Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core , 1994, Molecular and cellular biology.

[51]  R. Tuan,et al.  Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. , 1994, Development.

[52]  G. Grunwald,et al.  The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. , 1993, Current opinion in cell biology.

[53]  R. Bassel-Duby,et al.  A 40-kilodalton protein binds specifically to an upstream sequence element essential for muscle-specific transcription of the human myoglobin promoter , 1992, Molecular and cellular biology.

[54]  J. Riou,et al.  Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives. , 1991, Molecular pharmacology.

[55]  R. Hromas,et al.  Antisense oligonucleotides from the stage-specific myeloid zinc finger gene MZF-1 inhibit granulopoiesis in vitro , 1991, The Journal of experimental medicine.

[56]  L. Deaven,et al.  A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells. , 1991, The Journal of biological chemistry.

[57]  M. Sporn,et al.  Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[58]  E. Garattini,et al.  Isolation and characterization of the mouse liver/bone/kidney-type alkaline phosphatase gene. , 1990, The Biochemical journal.